Wysolone 20 Tablet DT contains Prednisolone 20mg, a synthetic glucocorticoid with potent anti-inflammatory and immunosuppressive properties. It is primarily indicated for the treatment of various inflammatory and autoimmune conditions such as rheumatoid arthritis, systemic lupus erythematosus, allergic disorders, asthma, and certain dermatological diseases. Prednisolone exerts its effect by modulating the immune response and inhibiting the release of inflammatory mediators, thereby reducing swelling, redness, and pain. Wysolone 20 Tablet DT is designed as a dispersible tablet, allowing for rapid dissolution and ease of administration, particularly beneficial for patients with swallowing difficulties. The dosage and duration of therapy should be individualized based on the severity of the condition and patient response, with careful monitoring to minimize potential adverse effects. Common side effects may include hyperglycemia, hypertension, increased susceptibility to infections, osteoporosis, and gastrointestinal disturbances. Abrupt discontinuation should be avoided to prevent adrenal insufficiency; tapering under medical supervision is recommended. Wysolone 20 Tablet DT should be used cautiously in patients with diabetes, hypertension, peptic ulcers, or infections. It is contraindicated in systemic fungal infections and known hypersensitivity to corticosteroids. Regular follow-up and laboratory assessments are essential to ensure therapeutic efficacy and safety.